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Transient receptor potential channel vanilloid type 4 (TRPV4) is a Ca2+- and Mg2+-permeable cation
channel that inﬂuences oxidative metabolism and insulin sensitivity. The role of TRPV4 in pancre-
atic beta cells is largely unknown. Here, we characterize the role of TRPV4 in controlling intracellu-
lar Ca2+ and insulin secretion in INS-1E beta cells. Osmotic, thermal or pharmacological activation of
TRPV4 caused a rapid rise of intracellular Ca2+ and enhanced glucose-stimulated insulin secretion. In
the presence of the TRPV channel blocker ruthenium red (RuR) or after suppression of TRPV4 pro-
tein production, TRPV4 activators failed to increase [Ca2+]i and insulin secretion in INS-1E cells.
 2013 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Previous studies indicated that transient receptor potential
(TRP) channels are expressed in pancreatic beta cells and modulate
various pancreatic beta cell functions [1]. One of the TRP channels
is the transient receptor channel vanilloid receptor type 4 (TRPV4).
TRPV4 is thermosensitive and can be also activated by hypotonic
cell swelling [2] or moderate heating [3]. TRPV4-expressing neu-rons are present in brain structures controlling osmo- and thermo-
regulation. Concordantly, TRPV4 was implicated in central
integration of thermal and osmotic signals [3]. In addition, there
is evidence suggesting that TRPV4 regulates metabolic activity of
peripheral tissues. TRPV4 contributes to oxidative metabolism
and modulates insulin receptor signalling in adipocytes [4]. Dele-
tion of TRPV4 in mice leads to reduced blood glucose levels, im-
proves insulin sensitivity, and makes the animals resistant to
diet-induced obesity [4]. While TRPV4 plays a role in controlling
glycemia by modulating insulin activities in peripheral tissues, lit-
tle is known about the role of this channel in pancreatic beta cells.
To date, there is only one study available, showing that TRPV4 is
expressed in mouse pancreatic islets and min6 beta cells, where it
confers human islet amyloid polypeptide (hIAPP)-induced rise of
intracellular Ca2+ levels [5]. Despite these observations, there are
no data concerning the role of TRPV4 in regulating insulin secre-
tion in pancreatic beta cells.
We therefore studied the role of TRPV4 in modulating
intracellular Ca2+ and insulin secretion using the established and
well-characterized INS-1E pancreatic beta cell line [6,7]. Our study
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INS-1E beta cells. Notably, activation of TRPV4 by hypotonic, ther-
mal or pharmacological stimuli leads to increase of intracellular
Ca2+ concentration which translates into potentiation of glucose-
stimulated insulin release.
2. Materials and methods
2.1. Materials
Unless otherwise stated, all reagents were obtained from Sigma
(Deisenhofen, Germany). Medium and supplements for cell culture
were purchased from GIBCO Invitrogen (Karlsruhe, Germany) and
Biochrom AG (Berlin, Germany).
2.2. Cell culture
INS-1E cells were kindly provided by Dr. Pierre Maechler (Médi-
cal Universitaire, Genève, Switzerland). Cells were cultured in
RPMI-1640 medium as described [8].
2.3. Real-time PCR
Total RNA was isolated using RNAesay Mini Kit (Qiagen, Hilden,
Germany) and ﬁrst standard cDNA was synthesized, as described
[9]. Real-time PCR reaction was performed using a LightCycler Taq-
Man Master Kit (Roche Diagnostics, Petzburg, Germany) in a Light
Cycler 2.0 instrument (Roche Diagnostics). Results are shown as ra-
tio of TRPV4 to GAPDH expression. Primers and probes numbers are
given in Supplementary Table 1.
2.4. Western blot
Proteins were isolated from INS-1E cells using a RIPA buffer
containing: 50 mmol/l Tris–HCl, pH 8.0 with 150 mmol/l NaCl,
1.0% NP-40, 0.5% sodium deoxycholate, 0.1% SDS, 10 mmol/l
NaF and 1 mmol/l Na3(VO4) and supplemented with protease
inhibitor cocktail (Roche Diagnostics, Penzberg Germany), as re-
ported [9]. Membrane was blocked for 1 h using 5% bovine serum
albumin at room temperature and incubated with primary rabbit
polyclonal TRPV4 antibody (Alomone Labs, Jerusalem, Israel) di-
luted 1:500, at 4 C for 16 h. After incubation with primary anti-
body, membrane was washed with PBS-T (3  15 min) and
incubated with HRP-conjugated anti-rabbit secondary antibody,
diluted 1:5000 (Cell Signaling Technology, Danvers, MA, USA)
for 1 h at room temperature. Chemiluminescence reaction was
performed using Enhanced NuGlo Chemiluminescent Substrate
(Alpha Diagnostics Intl. Inc., San Antonio, TX, USA). Protein sig-
nals were visualized using light-sensitive X-ray ﬁlm. The signal
intensity was quantiﬁed using Quantity One 1-D Analysis Soft-
ware (Bio-Rad Laboratories, Munich, Germany). Membrane was
then stripped and incubated with antibody against b-actin (Sigma
Aldrich) diluted 1:10000 for loading control for approximately
16 h at 4 C.2.5. Transfection of INS-1E cells with siRNA
ON-TARGETplus SMART pool of four individual TRPV4 siRNAs
(1#: cguccaaaccugcguauga, 2#: ggacaaguggcguaaguuc, 3#: gcac-
cugucucgcaaguuc, 4#: gcacgccacccuaccuua) and non-targeting
siRNA were obtained from Thermo Scientiﬁc Dharmacon (Wal-
tham, MA, USA). INS-1E cells were plated in six-well plates with
cover slides (for calcium imaging) or in 24-well plates (for insulin
secretion assay). Cells were transfected with 100 nM non-target-
ing siRNA or 100 nM TRPV4 siRNA, using HiPerfect reagent (Qia-gen), according to the manufacturer’s protocol. The most efﬁcient
incubation time for the maximal suppression of endogenous
TRPV4 proteins was 48 h. After 48 h incubation time, proteins
were extracted from INS1-E cells and TRPV4 proteins were de-
tected by Western blot.
2.6. Calcium imaging
Changes of intracellular free Ca2+ ([Ca2+]i) were measured with
fura-2/AM ﬂuorescence, as described [8,9]. In brief, INS-1E cells
were pre-incubated with culture medium containing 1–2 lM
fura-2/AM for 30 min at 37 C and 5% CO2. Then, cells were washed
with the same extracellular bath solution, as used for following cal-
cium measurements to remove extracellular fura-2/AM. Composi-
tion of the sodium- and potassium-free solution: 120 mM NMDG,
5.4 mM CsCl, 1 mM MgCl2, 10 mM HEPES-acid, 10 mM glucose,
5 mM Ca2+. In addition, a Ringer-like solution was used containing
150 mM NaCl, 6 mM CsCl, 1 mM MgCl2, 10 mM glucose, 10 mM
HEPES and 1.5 mM CaCl2 (pH 7.4). In experiments employing
hypotonic stress, isotonic and hypotonic extracellular bath solu-
tions consisted either of the sodium- and potassium-free solution
mentioned above (290 mosm/l) or were diluted equally with dis-
tilled water for the hypoosmolarity experiments (145 mosm/l). Un-
less otherwise stated, fura-2 ﬂuorescence was measured at room
temperature (20 C) using a digital imaging system (TILL Photon-
ics, Munich, Germany) at wavelengths of 340 and 380 nm. 2–10
cells were measured at once using a shutter system. The ratio of
the measured ﬂuorescence f340nm/f380nm represents changes in
[Ca2+]i. Test agents were dissolved in dimethyl sulfoxide (DMSO).
Final concentrations of DMSO in incubation medium did not ex-
ceed 0.05%. Data were processed by TIDA version 5.05 (HEKA Elek-
tronik, Lambrecht, Germany). Graphs were created in SigmaPlot
version 9.01 (Systat Software, Erkrath, Germany).
2.7. Insulin secretion
INS-1E cells were plated in 24-well plates at the density of
1.5  105 and cultured for 48 h. Cells were then preincubated in
glucose-free Krebs–Ringer-HEPES buffer (KRHB) containing:
136 mM NaCl, 4.7 mM KCl, 1 mM CaCl2, 1.2 mM MgSO4, 1.2 mM
KH2PO2, 2 mM NaHCO3, 10 mM HEPES (pH 7.4) for 1 h. Thereafter,
cells were washed with KRHB and incubated in the same buffer
containing 2.8 or 16.7 mM glucose with or without 5 lM 4a-PDD
or DMSO (vehicle controls) for 60 min. After the incubation, KRHB
was collected and centrifuged at 240g for 5 min. Supernatants
were collected for insulin determination.
Pancreatic islets were isolated from adult male Wistar rats as
described [10] using a liberase RI solution (Roche Diagnostics).
Groups of ﬁve pancreatic islets were incubated for 15 min in
0.5 ml of KRHB buffer (pH 7.4) containing 0.5% free fatty acid
BSA (fraction V) with or without 5 lM 4a-PDD at 2.8, 6 and
16.7 mM glucose. After the incubation, KRHB was collected and
insulin concentration was determined using a High Range Rat Insu-
lin ELISA Kit (DRG Instruments GmbH, Germany, Marburg). The
detection limit of the assay was 1.5 lg/l.2.8. Statistical analysis
Statistical signiﬁcance was determined with Student’s t-test
(parametric two-tailed t-test). The parametric-free Wilcoxon–
Mann–Whitney rank-sum test was used for assessing whether
one of two samples of independent measurements tended to have
larger values than the other. P-values <0.05 (⁄) and P < 0.01 (⁄⁄)
were considered signiﬁcant. Data are means ± S.E.M. derived from
at least n = 3 experiments.
M. Skrzypski et al. / FEBS Letters 587 (2013) 3281–3287 32833. Results
3.1. TRPV4 expression in pancreatic INS-1E beta cells
TRPV4mRNA was expressed in INS-1E beta cells and rat pancre-
atic islets at levels comparable to kidney (positive control) (Fig. 1a).
The expected TRPV4 protein band of 110 kDa was detected in
INS-1E cells by Western blot. Since, the antibody also cross-reacted
with other proteins, we transfected INS1-E cells with TRPV4 siRNA
for 48 h. This resulted in approximately 70% reduction of the
110 kDa protein signal, as compared with cells transfected with
non-targeting siRNA (Fig. 1b and c). The intensity of other signals
was not affected, suggesting that the 110 kDa signal corresponds
to TRPV4. Overall, these data indicate the presence of TRPV4 on
RNA and protein level in INS-1E cells.nt-siRNA TRPV4-siRNA
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Fig. 1. Detection of TRPV4 in INS-1E beta cells by RT-PCR and Western blot. (A)
Relative expression of TRPV4 mRNA in INS-1E cells, pancreatic islets and kidneys
normalised to GAPDH. (B) Western blot detection of TRPV4 protein production in
INS-1E cells. Lanes 1 and 3: expression of TRPV4 in cells transfected with non-
targeting siRNA, lanes 2 and 4: expression of TRPV4 in cells transfected with TRPV4
siRNA. Note: a  70% reduction of 110 kDa protein (corresponds to the predicted
TRPV4 protein size) in cells transfected with TRPV4 siRNA. (C) Quantiﬁcation of
TRPV4 protein production normalized to b-actin as loading control. Data are shown
as mean ± S.E.M., derived from n = 4 replicates.3.2. TRPV4 is activated by hypotonic challenge in INS-1E cells
Initially, TRPV4 was reported to be activated by hypotonic solu-
tion [2]. To test the functionality of TRPV4 changes of [Ca2+]i were
measured in INS-1E cells incubated in a hypotonic solution
(145 mosm/l). The hypotonic challenge increased the f340nm/
f380nm ﬂorescence ratio, indicating a rise of [Ca2+]i (Fig. 2a). The in-
crease of [Ca2+]i was irreversible, despite washout. In Ca2+-free
hypotonic solution (supplemented with 1 mM EGTA), there was
no increase of [Ca2+]i (Fig. 2b). In the presence of the TRPV channel
blocker ruthenium red (10 lM), the rise of [Ca2+]i was strongly re-
duced (Fig. 2c). Furthermore, the rise of [Ca2+]i in the presence of
hypotonic solution was less pronounced in TRPV4 siRNA-transfec-
ted cells, as compared to cells transfected with non-targeting siR-
NA (Fig. 2d and e).
3.3. Activation of TRPV4 by heating
To speciﬁcally activate TRPV4, we exposed both, INS-1E cells
with normal endogenous TRPV4 protein levels and INS-1E cells
with TRPV4 protein production reduced by 70% to moderate heat-
ing (27 C). In this set of experiments, TRPV4 siRNA- or non-tar-
geting (nt) siRNA-treated cells were exposed for 240 s to 27.5 C
(±0.3 C) or 27.6 C (±0.2 C), respectively. Of note, the threshold
temperature activation for TRPV4 is 27 C [11,12]. As shown in
Fig. 3, non-targeting-siRNA-treated cells showed a rise of [Ca2+]i
after 290 s. In contrast, reduction of TRPV4 protein production in
INS-1E prevented the increase of [Ca2+]i induced by moderate heat-
ing. These data indicate that moderate heating activates TRPV4,
with the concomitant elevation of [Ca2+]i in INS-1E cells.
3.4. Pharmacological activation of TRPV4 by 4a-PDD
Application of 5 lM 4a-PDD, a TRPV4 agonist [13] increased
[Ca2+]i in INS-1E cells (Fig. 4a). This effect was irreversible, since
washout failed to restore [Ca2+]i to basal levels. 4a-PDD-induced
increase of [Ca2+]i was abolished in the presence of a Ca2+-free
solution (supplemented with 1 mM EGTA) (Fig. 4b). Furthermore,
the TRP channel blocker lanthanum III chloride (La3+) (100 lM) sig-
niﬁcantly reduced 4a-PDD-induced increase of [Ca2+]i (Fig. 4c). To
verify, whether the increase of [Ca2+]i was mediated via TRPV4,
INS-1E cells with TRPV4 protein production reduced by 70% were
used. As shown in Fig. 4d, nt siRNA-treated cells incubated with
3 lM 4a-PDD showed a signiﬁcant increase of [Ca2+]i at 300 and
480 s (ﬁlled circles), as compared to untreated control cells (open
circles). In contrast, cells with reduced TRPV4 protein production
did not show a signiﬁcant elevation of [Ca2+]i after 300 s of incuba-
tion with 4a-PDD and a markedly attenuated 4a-PDD-stimulated
Ca2+ inﬂux after 480 s as compared to cells pretreated with nt
siRNA.
3.5. TRPV4 activation stimulates insulin secretion
To study, whether TRPV4 activation is associated with changes
of insulin secretion, INS-1E cells were incubated at low (2.8 mM) or
high glucose (16.7 mM), with or without 5 lM 4a-PDD for 1 h. As
shown in Fig 5a, 4a-PDD increased insulin secretion at high glu-
cose concentration, only (Fig 5a). The ability of 4a-PDD to enhance
insulin release from INS-1E was abolished by 10 lM ruthenium red
(Fig 5b). Furthermore, 4a-PDD failed to potentiate glucose-stimu-
lated insulin secretion in INS-1E cells with reduced TRPV4 protein
production (Fig. 5c). The ability of 4a-PDD to increase insulin
secretion was also studied in isolated pancreatic islets (Fig. 5d).
4a-PDD increased insulin secretion at 2.8 and 6.0 mM glucose con-
centration above controls. At 16.7 glucose 4a-PDD showed a trend
toward enhancement of insulin release, however the difference
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Fig. 2. Changes of intracellular Ca2+ level in INS-1E cells exposed to hypotonic solution. Fura-2 loaded INS-1E cells were incubated in isotonic solution (290 mosm/l) for 300 s
and then switched to hypotonic solution (145 mosm/l) for additional 600 s (A). Note: the progressive increase in [Ca2+]i after application of hypotonic buffer and the lack of
further increase after washout. (B) Lack of effects of hypotonic challenge in a Ca2+ free solution (1 mM EGTA). Reduction of hypotonic stimulus-induced increase of [Ca2+]i in
INS-1E cells by the pharmacological blockade of TRPV4 using the TRPV channel blocker ruthenium red (10 lM) (C). (D and E) Consequences of TRPV4 down regulation using
siRNA on Ca2+ inﬂux induced by hypotonic solution. Data are shown as mean ± S.E.M. derived from n = 3–6 replicates.
3284 M. Skrzypski et al. / FEBS Letters 587 (2013) 3281–3287was not statistically signiﬁcant (P = 0.06). Overall, these data reveal
that TRPV4 activation by 4a-PDD potentiates glucose-induced
insulin secretion in INS-1E cells.
4. Discussion
In the present study, we identiﬁed TRPV4 channel expression
and described its function in pancreatic INS-1E beta cells. TRPV4
expression and function in INS-1E cells could be identiﬁed using
RT-PCR, Western blot as well as by ﬂuorimetric measurements of
calcium and by an insulin secretion assay. Classical stimuli of
TRPV4 activity such as hypotonic solution or moderate heating in-
creased Ca2+ inﬂux in INS-1E cells. In addition, also the pharmaco-
logical activation of TRPV4 by 4a-PDD increased [Ca2+]i. These
TRPV4-mediated Ca2+ responses correspond to those measured
by others in various cell types including tumor cells [14–16]. Nota-bly, this event was associated with enhanced glucose-induced
insulin secretion. Increases of [Ca2+]i were attenuated by the gen-
eral TRP channel blocker La3+ and more speciﬁcally by the TRPV
channel blocker ruthenium red. At the tested doses for RuR be-
tween 5 and 10 lM TRPV channel including TRPV4 can be blocked.
RuR was established for using as a TRPV channel tool in various
studies evaluating the functions of TRPV4 in different cell types
[15–17]. Finally, the lack of [Ca2+]i increase in response to 4a-
PDD treatment in INS-1 cells, in which a 70% reduction of TRPV4
protein levels was achieved, further supports the aforementioned
observations.
The increase of [Ca2+]i level plays an essential role in regulating
insulin secretion in pancreatic beta cells. In particularly, the rapid
Ca2+ inﬂux in beta cells is of signiﬁcant importance. This Ca2+ inﬂux
is caused by the increased glucose-dependent ATP synthesis, which
subsequently leads to closure of ATP-sensitive potassium channels
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þ
ATP channels results in plasma membrane depo-
larisation with a concomitant Ca2+ entry through voltage-operated
L-type Ca2+ channels and consequently evokes the beta cell degran-
ulation [18]. However, there is evidence suggesting that the rise of
[Ca2+]i is not only the consequence of K
þ
ATP-dependent pathway
activation, but can be also triggered by the activation of other
Ca2+ permeable ion channels, e.g., members of TRP channel family
[1]. Based on the outcome of our study, we propose a link between
TRPV4 activation and insulin release. Using the TRPV4 speciﬁc ago-
nist 4a-PDD, we showed that TRPV4 activation results in enhancedA
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Statistical evaluation of [Ca2+]i was performed after 3 lM 4a-PDD stimulation for 300 aglucose-stimulated insulin secretion. This ﬁnding was further
strengthened by the use of cells with markedly decreased TRPV4
protein production. Potentiation of insulin release by 4a-PDD
was lost in cells transfected with TRPV4 siRNA that led to a reduc-
tion of TRPV4 protein production.
Importantly, our study is limited to in vitro experiments; how-
ever the results of previous studies in conjunction with our current
data allows claiming that TRPV4-dependend calcium regulation
and insulin secretion may be of physiological relevance. According
to our knowledge, only one study addressing the role of TRPV4 in
pancreatic beta cells is available, up to date. Casas et al. [5] re-
ported that Ca2+ elevation in mouse beta cells treated with human
islets amyloid polypeptide was mediated via TRPV4. Furthermore,
the same authors reported that hIAPP-induced cytotoxicity was
partially reversed by silencing TRPV4 expression. Thus, these data
suggest that TRPV4 hyperactivity may confer cytotoxic effects of
hIAPP in beta cells and contribute to beta cell loss. Contribution
of TRPV4 activation in energy homeostasis was also reported by
Ye et al. [4]. The authors of this study reported that blockade of
TRPV4 protects mice from diet-induced obesity and attenuates
insulin resistance. Furthermore, TRPV4 null mice have reduced lev-
els of fasting and glucose-induced insulin secretion. Since hyperin-
sulinemia is a hallmark of insulin resistance [19], it is possible that
declined levels of plasma insulin observed in TRPV4 null mice re-
sult from improved insulin sensitivity. However, in the light of
our current results showing that TRPV4 activation potentiates
insulin secretion, these observations may suggest that the de-
creased plasma insulin levels in TRPV4 null mice resulted from
the deﬁciency of TRPV4. It is worth to notice that TRPV4 expression
and its functional activity are reduced by high glucose in cells of
the human collecting duct [20]. Therefore, functional alterations
of TRPV4 in diabetic patients are possible, which can be conse-
quently associated with impaired prandial insulin secretion.D
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30 min before 4a-PDD). (C) Effects of 16.7 mM glucose with or without 5 lM 4a-PDD on insulin secretion in INS-1E cells with TRPV4 protein levels suppressed by 70%.
Controls: INS-1E cells transfected with non-targeting siRNA. (D) Insulin secretion in isolated rat pancreatic islets incubated for 15 min with 2.8, 6.0 or 16.7 mM glucose with
or without 5 lM 4a-PDD. The graph shows the result of a typical experiment (mean ± S.E.M., derived from at least n = 4 replicates).
3286 M. Skrzypski et al. / FEBS Letters 587 (2013) 3281–3287Furthermore, the potential physiological relevance of TRPV4 in
controlling endocrine functions of beta cells in vivo is supported
by the results of our study in isolated rat pancreatic islets. How-
ever, in contrast to our ﬁndings in INS-1E beta cell line, 4a-PDD
was able to stimulate insulin secretion at low (2.8 mM) and inter-
mediate (6 mM) glucose concentrations. In the presence of high
glucose (16.7 mM) stimulation of insulin secretion by 4a-PDD just
missed the statistical signiﬁcance (P = 0.06). Reasons for the dis-
crepancies between the effects of 4a-PDD on insulin secretion in
INS-1E cells and isolated islets are unclear. It cannot be excluded
that at high glucose the stimulation of TRPV4 by 4a-PDD at high
glucose is attenuated by somatostatin, which secretion from pan-
creatic delta cells rises in the presence of high glucose [21].
Somatostatin is able to suppress insulin secretion. In addition,
somatostatin was also found to modulate TRPV1 receptor functions
[22]. Finally the presence of TRPV4 in delta cells and its contribu-
tion to glucose- and calcium-dependent somatostain secretion
may be also possible. To answer this question, experiments in
somatostatin-depleted islets will be necessary.
In our in vitro study, TRPV4 was activated by the pharmacolog-
ical agonist 4a-PDD. Hence, this raises a question, regarding exis-
tence of physiological modulators of TRPV4 activity in vivo.
Former studies found that, in addition to thermal and hypotonic
stimulation activation, TRPV4 is constantly active at low level in
the absence of speciﬁc stimuli [2]. Furthermore, TRPV4 activation
can be enhanced by PKC-dependent phosphorylation and activa-
tors of cAMP synthesis [23]. Thus, it is possible that constitutively
active TRPV4 may contribute to insulin secretion. In addition,
TRPV4 may also confer the effects of certain insulin secretagogues
in pancreatic beta cells, which have the known ability to activate
TRPV4 channel. This possibility is partially supported by earlier
data showing the importance of other TRPs family members in reg-ulating hormonal and glucose-evoked insulin secretion. It was re-
ported that mice with TRPM2 deﬁciency have impaired Ca2+
signalling and reduced insulin secretion in response to glucose or
incretins [24]. Therefore, the potential role of TRPV4 in controlling
the molecular machinery responsible for insulin secretion needs to
be studied in more detailed fashion.
In summary, our study shows the functional expression of
TRPV4 in pancreatic INS-1E beta cells. TRPV4 triggers glucose-
stimulated insulin secretion by modulating intracellular calcium.
Acknowledgments
M.Z.S., C.G., S.M. were supported by the Deutsche Forschungs-
gemeinschaft. MSk was supported the Narodowe Centrum Nauki
(Grant 2011/03/N/NZ4/02965). MSk is the recipient of a 2013 An-
nual Fellowship for Young Scientists from the Foundation for Polish
Science (FNP). We thank Professor Pierre Maechler (University of
Geneva Medical Center, Switzerland) for providing INS-1E cells.
Appendix A. Supplementary data
Supplementary data associated with this article can be found, in
the online version, at http://dx.doi.org/10.1016/j.febslet.2013.
08.025.
References
[1] Uchida, K. and Tominaga, M. (2011) The role of thermosensitive TRP (transient
receptor potential) channels in insulin secretion. Endocr. J. 58, 1021–1028.
[2] Strotmann, R., Harteneck, C., Nunnenmacher, K., Schultz, G. and Plant, T.D.
(2000) OTRPC4, a non-selective cation channel that confers sensitivity to
extracellular osmolarity. Nat. Cell Biol. 2, 695–702.
[3] Guler, A.D., Lee, H., Iida, T., Shimizu, I., Tominaga, M. and Caterina, M. (2002)
Heat-evoked activation of the ion channel, TRPV4. J. Neurosci. 22, 6408–6414.
M. Skrzypski et al. / FEBS Letters 587 (2013) 3281–3287 3287[4] Ye, L. et al. (2012) TRPV4 is a regulator of adipose oxidative metabolism,
inﬂammation, and energy homeostasis. Cell 151, 96–110.
[5] Casas, S., Novials, A., Reimann, F., Gomis, R. and Gribble, F.M. (2008) Calcium
elevation in mouse pancreatic beta cells evoked by extracellular human islet
amyloid polypeptide involves activation of the mechanosensitive ion channel
TRPV4. Diabetologia 51, 2252–2262.
[6] Watkins, S.L., Schmoll, D. and Burchell, A. (1997) INS-1 cells as a model for
studying the role of pancreatic glucose-6-phosphatase in glucokinase
dependent glucose-mediated insulin secretion. Biochem. Soc. Trans. 25, 71S.
[7] Merglen, A., Theander, S., Rubi, B., Chaffard, G., Wollheim, C.B. and Maechler, P.
(2004) Glucose sensitivity and metabolism-secretion coupling studied during
two-year continuous culture in INS-1E insulinoma cells. Endocrinology 145,
667–678.
[8] Mergler, S., Singh, V., Grotzinger, C., Kaczmarek, P., Wiedenmann, B. and
Strowski, M.Z. (2008) Characterization of voltage operated R-type Ca2+
channels in modulating somatostatin receptor subtype 2- and 3-dependent
inhibition of insulin secretion from INS-1 cells. Cell. Signal. 20, 2286–2295.
[9] Mergler, S., Skrzypski, M., Sassek, M., Pietrzak, P., Pucci, C., Wiedenmann, B.
and Strowski, M.Z. (2012) Thermo-sensitive transient receptor potential
vanilloid channel-1 regulates intracellular calcium and triggers
chromogranin A secretion in pancreatic neuroendocrine BON-1 tumor cells.
Cell. Signal. 24, 233–246.
[10] Lacy, P.E. and Kostianovsky, M. (1967) Method for the isolation of intact islets
of Langerhans from the rat pancreas. Diabetes 16, 35–39.
[11] Plant, T.D.; Strotmann, R., TRPV4: a multifunctional nonselective cation
channel with complex regulation, in: Liedtke, W.B.; Heller, S. (Eds.), TRP Ion
Channel Function in Sensory Transduction and Cellular Signaling Cascades,
Boca Raton (FL): CRS Press, 2007, 125–140.
[12] Montell, C., The TRP superfamily of cation channels. Science STKE 2005 (2005)
re3.
[13] Watanabe, H. et al. (2002) Activation of TRPV4 channels (hVRL-2/mTRP12) by
phorbol derivatives. J. Biol. Chem. 277, 13569–13577.[14] Kochukov, M.Y., McNearney, T.A., Fu, Y. and Westlund, K.N. (2006)
Thermosensitive TRP ion channels mediate cytosolic calcium response in
human synoviocytes. Am. J. Physiol. Cell Physiol. 291, C424–C432.
[15] Pan, Z. et al. (2008) Dependence of regulatory volume decrease on transient
receptor potential vanilloid 4 (TRPV4) expression in human corneal epithelial
cells. Cell Calcium 44, 374–385.
[16] Mergler, S., Valtink, M., Taetz, K., Sahlmuller, M., Fels, G., Reinach, P.S.,
Engelmann, K. and Pleyer, U. (2011) Characterization of transient receptor
potential vanilloid channel 4 (TRPV4) in human corneal endothelial cells. Exp.
Eye Res. 93, 710–719.
[17] Marrelli, S.P., O’Neil, R.G., Brown, R.C. and Bryan Jr., R.M. (2007) PLA2 and
TRPV4 channels regulate endothelial calcium in cerebral arteries. Am. J.
Physiol. Heart Circ. Physiol. 292, H1390–H1397.
[18] Straub, S.G. and Sharp, G.W. (2002) Glucose-stimulated signaling pathways in
biphasic insulin secretion. Diabetes Metab. Res. Rev. 18, 451–463.
[19] Shanik, M.H., Xu, Y., Skrha, J., Dankner, R., Zick, Y. and Roth, J. (2008) Insulin
resistance and hyperinsulinemia: is hyperinsulinemia the cart or the horse?
Diabetes Care 31 (Suppl. 2), S262–S268.
[20] Hills, C.E., Bland, R. and Squires, P.E. (2012) Functional expression of TRPV4
channels in human collecting duct cells: implications for secondary
hypertension in diabetic nephropathy. Exp. Diabetes Res. 2012, 936518.
[21] Kanatsuka, A., Makino, H., Matsushima, Y., Osegawa, M., Kasanuki, J., Miyahira,
M., Yamamoto, M. and Kumagai, A. (1981) Effect of glucose on somatostatin
secretion from isolated pancreatic islets of normal and streptozotocin-diabetic
rats. Endocrinology 109, 652–657.
[22] Carlton, S.M., Zhou, S., Du, J., Hargett, G.L., Ji, G. and Coggeshall, R.E. (2004)
Somatostatin modulates the transient receptor potential vanilloid 1 (TRPV1)
ion channel. Pain 110, 616–627.
[23] Fan, H.C., Zhang, X. and McNaughton, P.A. (2009) Activation of the TRPV4 ion
channel is enhanced by phosphorylation. J. Biol. Chem. 284, 27884–27891.
[24] Uchida, K. et al. (2011) Lack of TRPM2 impaired insulin secretion and glucose
metabolisms in mice. Diabetes 60, 119–126.
